ArticleDiabetology & metabolic syndrome2025

Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study.

Makoto Ohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.